
Terns Pharmaceuticals: Early-Stage Biopharma Worthy Of Your Attention (NASDAQ:TERN)
white drugs in bulk, drops, a syringe, an ampoule with drugs. Alina Lyssenko Our biopharma hedge fund screener at BPIQ.com, revealed that Terns Prescription drugs (NASDAQ:TERN) grew to become a high 20 holding in 5 of 36 biopharma funds throughout This autumn, which gave us the concept to look nearer into this small-cap biopharma firm….